Roy Beveridge
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
Papers in
- Oncology 24
- Cancer Treatment and Pharmacology 6
- Neutropenia and Cancer Infections 5
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 3
-
- Economic and Financial Impacts of Cancer 9
- Health Systems, Economic Evaluations, Quality of Life 5
- Co-authors
- Nancy E. Davidson (2 shared papers)J. Russell Hoverman (9 shared papers)Martin D. Abeloff (2 shared papers)Michael Kolodziej (5 shared papers)Marcus A. Neubauer (5 shared papers)Gary Gordon (1 shared paper)Robert M. Rifkin (5 shared papers)J. Cameron Muir (1 shared paper)
- Journals
- Journal of Clinical Oncology (12 papers)Journal of Oncology Practice (5 papers)Blood (4 papers)Journal of the National Comprehensive Cancer Network (3 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Roy Beveridge
61 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 110
- Oncology 492
- Hematology 177
- Cancer Research 195
- Public Health, Environmental and Occupational Health 196
- Economics and Econometrics 170
Countries citing papers authored by Roy Beveridge
This map shows the geographic impact of Roy Beveridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Beveridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Beveridge more than expected).
Fields of papers citing papers by Roy Beveridge
This network shows the impact of papers produced by Roy Beveridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Beveridge. The network helps show where Roy Beveridge may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy Beveridge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 141 | |
| 2 | 1991 | 128 | |
| 3 | 2010 | 96 | |
| 4 | 2000 | 93 | |
| 5 | 1997 | 88 | |
| 6 | 2011 | 84 | |
| 7 | 1980 | 69 | |
| 8 | 1993 | 59 | |
| 9 | 2003 | 58 | |
| 10 | 1993 | 56 | |
| 11 | 2000 | 46 | |
| 12 | 2011 | 45 | |
| 13 | 2001 | 37 | |
| 14 | 2008 | 36 | |
| 15 | 2003 | 33 | |
| 16 | 1990 | 33 | |
| 17 | 1986 | 33 | |
| 18 | 2010 | 30 | |
| 19 | 1996 | 26 | |
| 20 | 2002 | 24 |
About Roy Beveridge
Roy Beveridge is a scholar working on Oncology, Economics and Econometrics, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 62 papers that have together received 1.5k indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (9 papers), Cancer Treatment and Pharmacology (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Neutropenia and Cancer Infections (5 papers), Cancer Genomics and Diagnostics (4 papers), Breast Cancer Treatment Studies (3 papers), Cancer Cells and Metastasis (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (492 citations), Hematology (177 citations), Cancer Research (195 citations), Public Health, Environmental and Occupational Health (196 citations) and Economics and Econometrics (170 citations). Roy Beveridge has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Nancy E. Davidson, J. Russell Hoverman, Martin D. Abeloff, Michael Kolodziej, Marcus A. Neubauer, Gary Gordon, Robert M. Rifkin, J. Cameron Muir, Richard L. Weinberg and Richard L. Theriault. Their work appears in journals such as Journal of Clinical Oncology, Journal of Oncology Practice, Blood, Journal of the National Comprehensive Cancer Network and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.